Hauke Busch

[Hauke Busch @BuschLab]

Our new view on the pathophysiology of pemphigus. Finally out as a preprint. https://t.co/1Gyqc70mWW

[Hauke Busch @BuschLab]

Successful FDM Törn on Sep 11th. An exciting day on research data management at ⁦@UniLuebeck⁩ , ⁦@th_luebeck⁩ and Schleswig Holstein. https://t.co/Nc9tjmrCEC

[Hauke Busch @BuschLab]

Join us on October 2nd for our day of single cell technology and services @UniLuebeck together with @10xGenomics register here https://t.co/QKJoiEvrYL

[Hauke Busch @BuschLab]

Sexdiversity - „Geschlecht hat viele Ebenen“
https://t.co/H17io9sFsP interesting podcast on our new CRC 1665 Sexdiversity.

[Hauke Busch @BuschLab]

Interesting discussion on #immune therapy in #cancer vs. #autoimmunity . While oncology is ahead, you have to be more cautious w.r.t. toxicity in #autoimmunity

[Hauke Busch @BuschLab]

At the conference for autoimmunity in Ljubljana #Autoimmunity2024

[Hauke Busch @BuschLab]

@UKSH_KI_HL @IET_Sebens @Bildung_SH Respect for all participants. Icecold at HH airport. Flying to warm waters at the Gulf to fight cancer together with U of Sharjah.

[Hauke Busch @BuschLab]

We did it. Certified as a center for personalized medicine in oncology. Congratulations and thanks to all the people involved. ⁦@UniLuebeck⁩ ⁦@UKSH_KI_HL⁩ ⁦⁦@medinflame⁩ https://t.co/N8wPflNwmb

[Hauke Busch @BuschLab]

Our paper on post-COVID syndrome is out on biorxiv. scRNA-seq reveals persistent aberrant differentiation of nasal epithelium driven by TNFα and TGFβ. https://t.co/JzBTSLPk9U

[Hauke Busch @BuschLab]

Nice work! And already implemented for potential use in the Molecular Tumor Board of the UKSH @UKSH_KI_HL @knstnr

[EMBL-EBI @emblebi]

The new AlphaMissense catalogue from @GoogleDeepMind can be used with the @ensembl Variant Effect Predictor to predict variant pathogenicity and therefore aid interpretation.

https://t.co/AMAnSs9ScW

[Hauke Busch @BuschLab]

Happy to announce that our university cancer center #uccsh is now member of the German network for personalized medicine. A big step for precision medicine to Schleswig-Holstein ⁦@UKSH_KI_HL⁩ ⁦@medinflame⁩ ⁦@UniLuebeck⁩ ⁦@kieluni⁩ https://t.co/6h6Og1Fguu

[Hauke Busch @BuschLab]

Single Cell Multi-Omics to Analyse the Immune System. A webinar by Anke from our group. In collaboration with Singleron. Next week Friday 22nd. Looking forward to it. ⁦@UniLuebeck⁩ ⁦@UKSH_KI_HL⁩ ⁦@medinflame⁩ ⁦@Singleron_Bio⁩ https://t.co/j0at8ALT5Q

[Hauke Busch @BuschLab]

On the way to the German Emirati Conference at the University of Sharjah @uSharjah Looking forward to the science and the people @UniLuebeck

[Hauke Busch @BuschLab]

Yesterday - now Dr. - Michael Olbrich defended his PhD thesis on Bat h effects in microbiome data. Well done Michael. Congratulations.

[Hauke Busch @BuschLab]

Just visited Timo and his 350kgs/2,50m brand-new trapped ion mobility spectrometer from #Bruker Taking proteomics to the next level. Nice. @UniLuebeck @UKSH_KI_HL

[Hauke Busch @BuschLab]

Got this delivered yesterday. Installing next week. #nanostring Looking forward to data in cancer, skin and inflammation @medinflame @DererStefanie @UKSH_KI_HL

[Cell Reports @CellReports]

Erythropoietin-driven dynamic proteome adaptations during erythropoiesis prevent iron overload in the developing embryo https://t.co/dIqTBtSvV2

[Hauke Busch @BuschLab]

Today was the first time we used our adaptation of @cbioportal successfully in the @UKSH_KI_HL Molecular tumor board. Nice to see medical informatics in action. @MIRACUM_de

[Hauke Busch @BuschLab]

Meeting of the current batch of PhD students from the @uSharjah with our president @UniLuebeck The students are always a breeze. So nice to have them here

[Hauke Busch @BuschLab]

Sad day for German science. We can spend billions on weapons but no money for science and exchange? The ⁦@DAAD_Germany⁩ is one of the best ambassadors and peace keepers Germany can have. What a shame! https://t.co/3BboCFvKN3